Amarantus Bioscience Holdings Inc (AMBS)

[MagicCap]

Conservatively: Mkt Cap of AMBS = $10 Million
*Assuming 250 million shares outstanding which is probably too high.

Compare this to some other penny stocks with far less potential:

TAGG - Current market cap of $24 Million; peak was over $100 Million
MJNA - Current market cap of $71 Million; peak was $95 Million
CBIS - Current market cap of $61 Milion; peak was almost $70 Million

When you take into account what Dr. Joseph Rubinfeld, co-founder of Amgen said ("I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug.") on November 6th, do you really think that the market cap should only be $10 Million? We have plenty of other companies pre trial or offering crap to customers like the penny stocks above that are trading at upwards of $100 Million or more.

Ask yourself if a company with a product described by the co-founder of AMGN as what "could be one of the biggest successes that I have ever seen" should be worth 1/10th of each of those companies above.

Come on people lets think for a second here.